posted
I have only been watching the penny stocks and this board for a week now, was doing some of my first DD and wanted to share a stock that i am planning on watching.
as this is my first post with stock info, my apologies if this is posted elsewhere...
noticed AVVW has been releasing some pr, appears to be at a low, upcoming run? (good lingo for the new guy, eh?
from yesterday:
Wall Street News Alert's Breaking Market News! February 15, 2005 WESTON, Fla., Feb. 15, 2005 (PRIMEZONE) -- Wall Street News Alert's "stocks to watch" this morning are: avVaa World Health Care Products Inc. (OTCBB:AVVW), Motorola, Inc. (NYSE:MOT), Aastrom Biosciences, Inc. (Nasdaq:ASTM) and Wal-Mart Stores, Inc. (NYSE:WMT).
Aggressive investors and traders need to be watching avVaa World Health Care Products Inc. (OTCBB:AVVW) this morning! Yesterday after the markets closed, the company, a global biotechnology company offering therapeutic, natural skin and health care products, issued a press release announcing that it has signed an agreement with an international sales and marketing consulting company.
This could be great news for investors! Under the terms of the agreement, Crossfire Network, Inc. has agreed to market and sell the full line of avVaa World Health Care Products Inc. in the U.S., Canada, Mexico and South American markets. The sole purpose of the agreement is for Crossfire to strategically market and sell avVaa products to major mass merchandisers, clubs, grocery, drug and convenience store chains. Initial sales and marketing program targets retail outlets in Mexico, where Crossfire has access to distributors in more than 20,000 pharmacies. Additionally, the Company is developing Internet sales for avVaa through one of the most successful Internet sales companies in the world, already under the Crossfire umbrella.
Investors continue to watch this company's progress! avVaa President and CEO Jack Farley said, "We are extremely pleased to have attracted such an established and successful sales and marketing firm to reach U.S., Canada, Mexico and South American markets with our proprietary skin care lines. Crossfire Network Inc. will give avVaa access to the necessary resources to open sales and marketing doors in North America and ensure the overall success of our sales plan for 2005."
According to the press release, distribution agreements with key worldwide contacts will be announced shortly.
Prior to yesterday's press release, the stock closed yesterday at twenty-four cents a share.
In case you are not familiar with the companies: avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin line of skin care products through mass, food and drug channels in the United States and globally.
Crossfire Network Inc. is an international marketing company that strategically places products with key retail outlets throughout North America. The Company has established relationships with top retail executives over twenty years that enable Crossfire to open retail doors to place clients' products quicker, faster and better than traditional in-house sales and marketing teams.
posted
finished way up today on this news. up 63% today alone. i wish i would have taken my own advice...
--------------------- ---------------------
avVaa Responds to Today's News That Competitors' Eczema Drugs Cause Cancer Risk avVaa Markets the Only Non-Toxic, All Natural OTC Eczema Treatment
FALKLAND, BC, Mar. 10, 2005 (MARKET WIRE via COMTEX) -- avVaa World Health Care Products Inc. (OTC BB: AVVW), a global biotechnology company offering therapeutic, natural skin and health care products, issued a statement today commenting on research published by the U.S. Food and Drug Administration (FDA) which found that the creams used to treat eczema from two major manufacturers are shown to cause cancer. The FDA requires that those creams must carry a "black box" warning, the strongest warning on medicines. The FDA also advised infants should not use these products.
Jack Farley, President and CEO of avVaa stated, "As the only manufacturer of proven, 98% natural and non-toxic eczema treatments which are registered FDA-compliant, this news is a watershed event for our Company. Our Company has long-believed there has been a tremendous, pent-up need for non-toxic eczema treatments. According to the National Institute of Health, about 15 million Americans are suffering from eczema, 20% of whom are children. avVaa stands ready to meet new demand on a global basis for healthier and safer alternatives to existing eczema treatments."
About avVaa World Health Care Products
avVaa World Health Care Products (AVVW) is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin line of skin care products through mass, food and drug channels in the United States and globally.
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
avVaa Responds to Today's News That Competitors' Eczema Drugs Cause Cancer Risk avVaa Markets the Only Non-Toxic, All Natural OTC Eczema Treatment
FALKLAND, BC, Mar. 10, 2005 (MARKET WIRE via COMTEX) -- avVaa World Health Care Products Inc. (OTC BB: AVVW), a global biotechnology company offering therapeutic, natural skin and health care products, issued a statement today commenting on research published by the U.S. Food and Drug Administration (FDA) which found that the creams used to treat eczema from two major manufacturers are shown to cause cancer. The FDA requires that those creams must carry a "black box" warning, the strongest warning on medicines. The FDA also advised infants should not use these products.
Jack Farley, President and CEO of avVaa stated, "As the only manufacturer of proven, 98% natural and non-toxic eczema treatments which are registered FDA-compliant, this news is a watershed event for our Company. Our Company has long-believed there has been a tremendous, pent-up need for non-toxic eczema treatments. According to the National Institute of Health, about 15 million Americans are suffering from eczema, 20% of whom are children. avVaa stands ready to meet new demand on a global basis for healthier and safer alternatives to existing eczema treatments."
About avVaa World Health Care Products
avVaa World Health Care Products (AVVW) is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin line of skin care products through mass, food and drug channels in the United States and globally.
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
